These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29784728)

  • 1. CYP2D6 Allelic Variants *34, *17-2, *17-3, and *53 and a Thr309Ala Mutant Display Altered Kinetics and NADPH Coupling in Metabolism of Bufuralol and Dextromethorphan and Altered Susceptibility to Inactivation by SCH 66712.
    Glass SM; Martell CM; Oswalt AK; Osorio-Vasquez V; Cho C; Hicks MJ; Mills JM; Fujiwara R; Glista MJ; Kamath SS; Furge LL
    Drug Metab Dispos; 2018 Aug; 46(8):1106-1117. PubMed ID: 29784728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of cytochrome P450 2D6.1 (CYP2D6.1), CYP2D6.2, and CYP2D6.17 activities toward model CYP2D6 substrates dextromethorphan, bufuralol, and debrisoquine.
    Marcucci KA; Pearce RE; Crespi C; Steimel DT; Leeder JS; Gaedigk A
    Drug Metab Dispos; 2002 May; 30(5):595-601. PubMed ID: 11950793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional characterization of 17 CYP2D6 allelic variants (CYP2D6.2, 10, 14A-B, 18, 27, 36, 39, 47-51, 53-55, and 57).
    Sakuyama K; Sasaki T; Ujiie S; Obata K; Mizugaki M; Ishikawa M; Hiratsuka M
    Drug Metab Dispos; 2008 Dec; 36(12):2460-7. PubMed ID: 18784265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of genetic variants of human P450 oxidoreductase on catalysis by CYP2D6 in vitro.
    Sandee D; Morrissey K; Agrawal V; Tam HK; Kramer MA; Tracy TS; Giacomini KM; Miller WL
    Pharmacogenet Genomics; 2010 Nov; 20(11):677-86. PubMed ID: 20940534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative metabolic capabilities and inhibitory profiles of CYP2D6.1, CYP2D6.10, and CYP2D6.17.
    Shen H; He MM; Liu H; Wrighton SA; Wang L; Guo B; Li C
    Drug Metab Dispos; 2007 Aug; 35(8):1292-300. PubMed ID: 17470523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro functional assessment of 22 newly identified CYP2D6 allelic variants in the Chinese population.
    Dai DP; Geng PW; Wang SH; Cai J; Hu LM; Nie JJ; Hu JH; Hu GX; Cai JP
    Basic Clin Pharmacol Toxicol; 2015 Jul; 117(1):39-43. PubMed ID: 25469868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of bufuralol, dextromethorphan, and 3,4-methylenedioxymethylamphetamine to wild-type and F120A mutant cytochrome P450 2D6 studied by resonance Raman spectroscopy.
    Bonifacio A; Keizers PH; Commandeur JN; Vermeulen NP; Robert B; Gooijer C; van der Zwan G
    Biochem Biophys Res Commun; 2006 May; 343(3):772-9. PubMed ID: 16563352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression, purification, and biochemical characterization of a human cytochrome P450 CYP2D6-NADPH cytochrome P450 reductase fusion protein.
    Deeni YY; Paine MJ; Ayrton AD; Clarke SE; Chenery R; Wolf CR
    Arch Biochem Biophys; 2001 Dec; 396(1):16-24. PubMed ID: 11716457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 22 Novel CYP2D6 Variants Found in the Chinese Population on the Bufuralol and Dextromethorphan Metabolisms In Vitro.
    Cai J; Dai DP; Geng PW; Wang SH; Wang H; Zhan YY; Huang XX; Hu GX; Cai JP
    Basic Clin Pharmacol Toxicol; 2016 Mar; 118(3):190-9. PubMed ID: 26310775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phe120 contributes to the regiospecificity of cytochrome P450 2D6: mutation leads to the formation of a novel dextromethorphan metabolite.
    Flanagan JU; Maréchal JD; Ward R; Kemp CA; McLaughlin LA; Sutcliffe MJ; Roberts GC; Paine MJ; Wolf CR
    Biochem J; 2004 Jun; 380(Pt 2):353-60. PubMed ID: 14992686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microsecond MD simulations of human CYP2D6 wild-type and five allelic variants reveal mechanistic insights on the function.
    Don CG; Smieško M
    PLoS One; 2018; 13(8):e0202534. PubMed ID: 30133539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis of CYP2D6.31 variant: homology modeling suggests possible disruption of redox partner interaction by Arg440His substitution.
    Allorge D; Bréant D; Harlow J; Chowdry J; Lo-Guidice JM; Chevalier D; Cauffiez C; Lhermitte M; Blaney FE; Tucker GT; Broly F; Ellis SW
    Proteins; 2005 May; 59(2):339-46. PubMed ID: 15726636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marmoset cytochrome P450 2D8 in livers and small intestines metabolizes typical human P450 2D6 substrates, metoprolol, bufuralol and dextromethorphan.
    Uehara S; Uno Y; Hagihira Y; Murayama N; Shimizu M; Inoue T; Sasaki E; Yamazaki H
    Xenobiotica; 2015; 45(9):766-72. PubMed ID: 25801057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of cimetidine on dextromethorphan O-demethylase activity of human liver microsomes and recombinant CYP2D6.
    Madeira M; Levine M; Chang TK; Mirfazaelian A; Bellward GD
    Drug Metab Dispos; 2004 Apr; 32(4):460-7. PubMed ID: 16680870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression, purification, and characterization of mouse CYP2d22.
    Yu AM; Haining RL
    Drug Metab Dispos; 2006 Jul; 34(7):1167-74. PubMed ID: 16595712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limited effects of frequent CYP2D6*36-*10 tandem duplication allele on in vivo dextromethorphan metabolism in a Japanese population.
    Kiyotani K; Shimizu M; Kumai T; Kamataki T; Kobayashi S; Yamazaki H
    Eur J Clin Pharmacol; 2010 Oct; 66(10):1065-8. PubMed ID: 20700584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A combination of mutations in the CYP2D6*17 (CYP2D6Z) allele causes alterations in enzyme function.
    Oscarson M; Hidestrand M; Johansson I; Ingelman-Sundberg M
    Mol Pharmacol; 1997 Dec; 52(6):1034-40. PubMed ID: 9415713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular dynamics of CYP2D6 polymorphisms in the absence and presence of a mechanism-based inactivator reveals changes in local flexibility and dominant substrate access channels.
    de Waal PW; Sunden KF; Furge LL
    PLoS One; 2014; 9(10):e108607. PubMed ID: 25286176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Tree Shrew Cytochrome P450 2Ds (CYP2D8a and CYP2D8b) Are Functional Drug-Metabolizing Enzymes that Metabolize Bufuralol and Dextromethorphan.
    Ushirozako G; Murayama N; Tsukiyama-Kohara K; Yamazaki H; Uno Y
    Drug Metab Dispos; 2024 Mar; 52(4):305-311. PubMed ID: 38262704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of G169R and P34S substitutions produced by mutations of CYP2D6*14 on the functional properties of CYP2D6 expressed in V79 cells.
    Shiraishi T; Hosokawa M; Kobayashi K; Tainaka H; Yamaura Y; Taguchi M; Chiba K
    Drug Metab Dispos; 2002 Nov; 30(11):1201-5. PubMed ID: 12386125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.